Fibroblast Growth Factor-2 Over-Rides Insulin-like Growth Factor-I Induced Proliferation and Cell Survival in Human Neuroblastoma Cells

Journal of Cellular Physiology

Volumn 199, Issue 3, 2004, Pages 371-380

  Russo, Vincenzo C ^a,b,c,d   Andaloro, E ^a,b   Fornaro, S A ^a,b,c   Najdovska, S ^a,b   Newgreen, D F ^b,c   Bach, L A ^a,c   Werther, G A ^a,b,c  

^a Centre for Hormone Research   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN C DERIVATIVE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; HUMAN; HUMAN CELL; MITOGENESIS; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 6; INSULIN-LIKE GROWTH FACTOR I; NEUROBLASTOMA; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 2342509136     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10416     Document Type: Article

References (80)

1. Abe K, Saito H. 2001. Effects of basic fibroblast growth factor on central nervous system functions. Pharmacol Res 43:307-312.
2. Arai T, et al. 1996a. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology 137:4571-4575.
3. Arai T, et al. 1996b. Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin. J Biol Chem 271:6099-6106.
4. Ay I, et al. 2001. Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res 87:71-80.
5. Baker NL, et al. 1999. Interactions between bcl-2 and the IGF system control apoptosis in the developing mouse brain. Brain Res Dev Brain Res 118:109-118.
6. Basilico C, Moscatelli D. 1992. The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115-165.
7. Baxter RC. 2000. Insulin-like growth factor (IGF)-binding proteins: Interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278(6):E967-E976.
8. Brooker GJ, et al. 2000. Endogenous IGF-1 regulates the neuronal differentiation of adult stem cells. J Neurosci Res 59(3):332-341.
9. Butt AJ, et al. 1999. The IGF axis and programmed cell death. Immunol Cell Biol 77:256-262.
10. Cardona-Gomez GP, et al. 2001. Interactions of estrogens and insulin-like growth factor-I in the brain: Implications for neuroprotection. Brain Res Brain Res Rev 37:320-334.
11. Chakravarthy MV, et al. 2000. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/ S cell cycle progression via the activation of phosphatidylinositol 3′-kinase/Akt signaling pathway. J Biol Chem 275:35942-35952.
12. Clemmons DR, et al. 1992. Competition for binding to insulin-like growth factor (IGF) binding protein-2, -3, -4, and -5 by the IGFs and IGF analogs. Endocrinology 131:890-895.
13. Clemmons DR. 1998. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 140:19-24.
14. Conover CA. 1992. Potentiation of insulin-like growth factor (IGF) action by IGF binding protein-3: Studies of underlying mechanism. Endocrinology 130:3191-3199.
15. Conover CA. 1996. Regulation and physiological role of insulin-like growth factor binding proteins. Endocr J 43(Suppl):S43-S48.
16. Creancier L, et al. 2000. Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J Cell Biol 150:275-281.
17. D'Ercole AJ, et al. 1996. The role of the insulin-like growth factors in the central nervous system [Review, 190 refs.]. Mol Neurobiol 13:227-255.
18. Dews M, et al. 2000. Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases. Endocrinology 141(4):1289-1300.
19. Dong F, et al. 2002. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells. J Cell Physiol 190: 63-73.
20. Drago J, et al. 1991. Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc Natl Acad Sci USA 88: 2199-2203.
21. Dupont J, et al. 2001. Insulin and IGF-1 induce different patterns Of gene expression in mouse fibroblast NIH-3T3 cells: Identification by cDNA microarray analysis. Endocrinology 142:4969-4975.
22. Ferguson KL, Slack RS. 2001. The Rb pathway in neurogenesis. Neuroreport 12:A55-A62.
23. Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854.
24. Frodin M, Gammeltoft S. 1994. Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation. Proc Natl Acad Sci USA 91:1771-1775.
25. Gage FH, et al. 1995. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci USA 92:11879-11883.
26. Grellier P, et al. 1998. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res 58:1670-1676.
27. Grimberg A, Cohen P. 2000. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183(1):1-9.
28. Gucev ZS, et al. 1997. Evidence for insulin-like growth factor (IGF)-independent transcriptional regulation of IGF binding protein-3 by growth hormone in SKHEP-1 human hepatocarcinoma cells. Endocrinology 138:1464-1470.
29. Hansen MB, et al. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210.
30. Hernandez-Sanchez C, et al. 1997. Differential regulation of insulin-like growth factor-I (IGF-I) receptor gene expression by IGF-I and basic fibroblastic growth factor. J Biol Chem 272:4663-4670.
31. Hoeflich A, et al. 2002. Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP-2 in vivo. FEBS Lett 523:63-67.
32. Hoekman K, et al. 1999. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma. Clin Endocrinol (Oxf) 51:247-253.
33. Hossenlopp P, et al. 1986. Analysis of serum insulin-like growth factor binding proteins using Western blotting. Use of the method for titration of the binding proteins and competitive binding studies. Anal Chem 154:138-143.
34. Janet T, et al. 1995. Heterogeneity of human neuroblastoma cell lines in their proliferative responses to basic FGF, NGF, and EGF: Correlation with expression of growth factors and growth factor receptors. J Neurosci Res 40:707-715.
35. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: Biological actions [Review, 345 refs.]. Endocr Rev 16:3-34.
36. Kiess W, et al. 1997. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: Variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation. Regul Pept 72:19-29.
37. Kim B, et al. 1998. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Endocrinology 139:4881-4889.
38. Kolsch H, et al. 1999. The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. Brain Res 818:171-175.
39. Lavenius E, et al. 1994. Basic FGF and IGF-I promote differentiation of human SH-SY5Y neuroblastoma cells in culture. Growth Factors 10:29-39.
40. Lawrence JB, et al. 1999. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149-3153.
41. Leventhal PS, et al. 1995. Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells. Exp Cell Res 221:179-186.
42. Lichtenwalner RJ, et al. 2001. Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis. Neuroscience 107:603-613.
43. Linseman DA, et al. 2002. Suppression of death receptor signaling in cerebellar Purkinje neurons protects neighboring granule neurons from apoptosis via an insulin-like growth factor I-dependent mechanism. J Biol Chem 277:24546-24553.
44. Marinaro JA, et al. 1999. HaCaT human keratinocytes express IGF-II, IGFBP-6, and an acid-activated protease with activity against IGFBP-6. Am J Physiol 276(Pt. 1):E536-E542.
45. Marinaro JA, et al. 2000. O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis. Eur J Biochem 267:5378-5386.
46. Menouny M, et al. 1998. IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. Int J Cancer 77:874-879.
47. Morrione A, et al. 2000. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells. Cancer Res 60(8):2263-2272.
48. Morrione A, et al. 2001. The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells. Oncogene 20:4842-4852.
49. Murashita MM, et al. 1995. Identification of insulin-like growth factor binding proteins from cultured human epidermal keratinocytes. J Cell Physiol 163:339-345.
50. Nibu K, et al. 2000. bFGF induces differentiation and death of olfactory neuroblastoma cells. Biochem Biophys Res Commun 279:172-180.
51. Niesler CU, et al. 2000. IGF-I inhibits apoptosis induced by serum withdrawal, but potentiates TNF-alpha-induced apoptosis, in 3T3-L1 preadipocytes. J Endocrinol 167:165-174.
52. Nishimura T, et al. 1999. Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. Biochim Biophys Acta 1444:148-151.
53. Oh Y, et al. 1993. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Endocrinology 132:1337-1344.
54. Olashaw NE, et al. 1987. Control of late G0/G1 progression and protein modification by SmC/IGF I. Am J Physiol 253:C575-C579.
55. Palmer TD, et al. 1999. Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS. J Neurosci 19:8487-8497.
56. Parker A, et al. 1998. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Mol Biol Cell 9:2383-2392.
57. Peruzzi F, et al. 1999. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19:7203-7215.
58. Peruzzi F, et al. 2001. Anti-apoptotic signaling of the insulin-like growth factor-I receptor through mitochondrial translocation of c-Raf and Nedd4. J Biol Chem 276:25990-25996.
59. Prisco M, et al. 1999. Insulin and IGF-I receptors signaling in protection from apoptosis. Horm Metab Res 31:80-89.
60. Raballo R, et al. 2000. Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex. J Neurosci 20:5012-5023.
61. Raguenez G, et al. 1999. BCL-2 is upregulated in human SH-SY5Y neuroblastoma cells differentiated by overexpression of fibroblast growth factor 1. Biochem Biophys Res Commun 258: 745-751.
62. Rosenthal SM, et al. 1991. Fibroblast growth factor inhibits insulin-like growth factor-II (IGF-II) gene expression and increases IGF-I receptor abundance in BC3H-1 muscle cells. Mol Endocrinol 5:678-684.
63. Rubin R, Baserga R. 1995. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab Invest 73:311-331.
64. Russo VC, Werther GA. 1994. Des (1-3) IGF-I potently enhances differentiated cell growth in olfactory bulb organ culture. Growth Factors 11:301-311.
65. Russo VC, et al. 1994. Identification, localization, and regulation of insulin-like growth factor binding proteins and their messenger ribonucleic acids in the newborn rat olfactory bulb. Endocrinology 135:1437-1446.
66. Russo VC, et al. 1997. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology 138:4858-4867.
67. Russo VC, et al. 1999. Basic fibroblast growth factor induces proteolysis of secreted and cell membrane-associated insulin-like growth factor binding protein-2 in human neuroblastoma cells. Endocrinology 140:3082-3090.
68. Sahni M, et al. 1999. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 13:1361-1366.
69. Sharif S, et al. 2001. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 7:1057-1062.
70. Shinada M, et al. 2000. Proteolysis of insulin-like growth factor-binding protein-3 is increased in urine from patients with diabetic nephropathy. J Clin Endocrinol Metab 85(3):1163-1169.
71. Singleton JR, et al. 1996a. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J Biol Chem 271:31791-31794.
72. Singleton JR, et al. 1996b. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res 56:4522-4529.
73. Takeda A, et al. 2000. Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J Biol Chem 275:5395-5399.
74. Torres-Aleman I, et al. 1990. Trophic effects of basic fibroblast growth factor on fetal rat hypothalamic cells: Interactions with insulin-like growth factor I. Brain Res Dev Brain Res 52:253-257.
75. Vaccarino FM, et al. 1999. Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis. Nat Neurosci 2:246-253.
76. Valentinis B, et al. 1995. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367.
77. Voigt A, et al. 2000. Differentiation, proliferation and adhesion of human neuroblastoma cells after treatment with retinoic acid. Cell Adhes Commun 7:423-440.
78. Wagle A, Singh JP. 2000. Fibroblast growth factor protects nitric oxide-induced apoptosis in neuronal SHSY-5Y cells. J Pharmacol Exp Ther 295:889-895.
79. Yokoyama Y, et al. 1997. Enhancement of apoptosis in developing chick neural retina cells by basic fibroblast growth factor. J Neurochem 68:2212-2215.
80. Zheng WH, et al. 2002. Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase(Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. Mol Pharmacol 62:225-233.